chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dysphonia, Erythema, Illness, Impaired work ability
Clinical narrative: Anaphylaxis & Rash Narrative: Employee with h/o prolonged laryngitis following illnesses who was returned to work earlier this week following an extended absence for the same, developed laryngitis following vaccination with Moderna. Additionally she developed a rash on the lateral aspects of her neck, down to her clavicles that was warm to the touch. Rash was not raised. She developed the same type of erythema above and below where the BP cuff had been placed. Sats were 100%, HR 98, BP in the 150s/90. she was given 25 mg of PO Benadryl. When she felt her throat tightening, she was escorted to the ED. In ED symptoms had expanded to include: "chest tightness, hoarseness, palpitations, " In the ED, she was given: 25mg IV benadryl, 60 prednisone. Laryngoscopy was performed with following results; "post cricoid edema which is nonspecific and no evidence of laryngeal edema." The ED concluded that because multiple organ systems were not involved this is "suspicious for an adverse reaction" but unlikely to be anaphylaxis. Employee discharged on PO prednisone and given a steroid dose pack.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Laryngeal oedema, Laryngitis, Laryngoscopy abnormal, Palpitations, Rash
Clinical narrative: Anaphylaxis & Rash Narrative: Employee with h/o prolonged laryngitis following illnesses who was returned to work earlier this week following an extended absence for the same, developed laryngitis following vaccination with Moderna. Additionally she developed a rash on the lateral aspects of her neck, down to her clavicles that was warm to the touch. Rash was not raised. She developed the same type of erythema above and below where the BP cuff had been placed. Sats were 100%, HR 98, BP in the 150s/90. she was given 25 mg of PO Benadryl. When she felt her throat tightening, she was escorted to the ED. In ED symptoms had expanded to include: "chest tightness, hoarseness, palpitations, " In the ED, she was given: 25mg IV benadryl, 60 prednisone. Laryngoscopy was performed with following results; "post cricoid edema which is nonspecific and no evidence of laryngeal edema." The ED concluded that because multiple organ systems were not involved this is "suspicious for an adverse reaction" but unlikely to be anaphylaxis. Employee discharged on PO prednisone and given a steroid dose pack.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm, Throat tightness
Clinical narrative: Anaphylaxis & Rash Narrative: Employee with h/o prolonged laryngitis following illnesses who was returned to work earlier this week following an extended absence for the same, developed laryngitis following vaccination with Moderna. Additionally she developed a rash on the lateral aspects of her neck, down to her clavicles that was warm to the touch. Rash was not raised. She developed the same type of erythema above and below where the BP cuff had been placed. Sats were 100%, HR 98, BP in the 150s/90. she was given 25 mg of PO Benadryl. When she felt her throat tightening, she was escorted to the ED. In ED symptoms had expanded to include: "chest tightness, hoarseness, palpitations, " In the ED, she was given: 25mg IV benadryl, 60 prednisone. Laryngoscopy was performed with following results; "post cricoid edema which is nonspecific and no evidence of laryngeal edema." The ED concluded that because multiple organ systems were not involved this is "suspicious for an adverse reaction" but unlikely to be anaphylaxis. Employee discharged on PO prednisone and given a steroid dose pack.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain
Clinical narrative: Headache achy nasuea  Narrative:
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: Headache, Myalgia, Fever & NauseaVomiting Narrative:
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Myalgia, Occupational exposure to SARS-CoV-2, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/05, Pfizer, dose #1 06/02 , Pfizer, dose #2 08/19 COVID swab, result: not detected 09/01 pt cc: cough, myalgias, rhinorrhea exposure: co worker 09/02 COVID swab, result: detected 09/02 SARS-COV-2 LINEAGE result: AY10 09/02 SARS-COV-2 CLADE result: 21 J (DELTA)
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/05, Pfizer, dose #1 06/02 , Pfizer, dose #2 08/19 COVID swab, result: not detected 09/01 pt cc: cough, myalgias, rhinorrhea exposure: co worker 09/02 COVID swab, result: detected 09/02 SARS-COV-2 LINEAGE result: AY10 09/02 SARS-COV-2 CLADE result: 21 J (DELTA)
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/17/2020, Pfizer, dose #1 01/07/2021 Pfizer, dose #2 09/02 COVID swab, result: detected 09/02 pt cc: exposure: unknown 09/23 COVID swab, result: NOT detected 09/12 clinically resolved
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/14/2020, Pfizer, dose #1 01/04/2021 , Pfizer, dose #2 09/02 COVID swab, result: detected 09/02 pt cc: exposure: unknown 09/13 clinically resolved
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Bradycardia, Cardiac monitoring, Fatigue
Clinical narrative: Narrative: Patient with a history of COVID pneumonia and transaminitis 12/29/2020, HTN, PTSD, anxiety, TIA (2016?). Patient presented to outside hospital 5/18/2021 after episode of profound fatigue and possible syncopal episode. While hospitalized, negative for PE, orthostatics negative. Had asymptomatic bradycardic episodes in the 40s. AKI improved with hydration. At last PCP visit, patient with cardiac monitoring in place and receiving follow-up care with local cardiologist. Patient believes episode may be an adverse event to his March 2021 COVID vaccination.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, COVID-19, Dyspnoea, Glomerular filtration rate decreased
Clinical narrative: Narrative:  83yr male direct admit from OSH on 10/14 due to symptomatic COVID-19 infection. Was not requiring oxygen supplementation until 10/15 desats to the high 70s with movement then back to low 90s on 4L O2. COVID Symptoms History: tested positive on 10/12 with dyspnea. High risk clinical conditions: HTN, CKD, COPD, colon cancer s/p right hemicolectomy (2015). COVID Therapeutics: dexamethasone 6mg daily plus remdesivir x 3 doses (d/c due to RA O2 and INC in LFTs). COVID Vaccination Status: Moderna x 2 Feb and March 2021. Hospitalization course: 6 days discharge on RA at 97% Sp02. Pertinent Labs: COVID Test: Positive 10/12/2021 eGFR 37ml/min (10/15; when remdesivir was started) AST/ALT 50H/40 (10/15; when remdesivir was started) AST/ALT 194/162 H (10/17) <10xULN
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Liver function test increased, Oxygen saturation decreased, SARS-CoV-2 test positive
Clinical narrative: Narrative:  83yr male direct admit from OSH on 10/14 due to symptomatic COVID-19 infection. Was not requiring oxygen supplementation until 10/15 desats to the high 70s with movement then back to low 90s on 4L O2. COVID Symptoms History: tested positive on 10/12 with dyspnea. High risk clinical conditions: HTN, CKD, COPD, colon cancer s/p right hemicolectomy (2015). COVID Therapeutics: dexamethasone 6mg daily plus remdesivir x 3 doses (d/c due to RA O2 and INC in LFTs). COVID Vaccination Status: Moderna x 2 Feb and March 2021. Hospitalization course: 6 days discharge on RA at 97% Sp02. Pertinent Labs: COVID Test: Positive 10/12/2021 eGFR 37ml/min (10/15; when remdesivir was started) AST/ALT 50H/40 (10/15; when remdesivir was started) AST/ALT 194/162 H (10/17) <10xULN
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient received his Moderna COVID vaccine #1 on 7/28/21 and his second vaccine on 8/25/21. No further notes or scanned records entered to indicate that he had issues with his vaccine or cause of death. A date of death was recorded as 9/15/21. There were 21 days from the second vaccine to his date of death.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Narrative: Patient with breakthrough covid infection. Tested positive 8/31/21. 2 doses of moderna vaccine received outside of facility
Age: 87.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Cardiac flutter, Chest pain, Electrocardiogram normal, Fatigue, Palpitations
Clinical narrative: Narrative: Pt with history of hypothyroid, HL, HTN, BPH. Pt c/o "stabbing" chest pain, palpitations, fluttering of the chest, and fatigue after receiving vaccines. No sob or other symptoms. Pt stated "I did not have anything to eat today." Pt's initial vitals were b/p 189/82, p-55, O2 sat 97% on RA. Upon reassessment BP is 160/101 and pt stated that his chest pain is resolved. With pt's permission, EMS was called and pt was transferred to ED for further evaluation. In ED patient reports pain resolved in about 1 minute. No shortness of breath, nausea, sweating, dizziness or weakness. Has not had any significant cardiac history nor any symptoms previously. EKG was negative; not thought to be cardiac in nature given is history of no symptoms and normal stress in 2019 at age of 85
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative: Patient with breakthrough Covid infection. Received two doses of moderna vaccine previously. Treated with monoclonal antibody therapy.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Narrative: Received initial COVID-19 Moderna series through Facility (3/19/21 and 4/16/21). Received third COVID-19 Moderna dose at Facility 09/30/21. Received notification that patient received third Pfizer COVID-19 vaccine dose 9/13/21. Error detected by database. Unknown if any ADRs.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative: Patient with Breakthrough covid infection 2 doses of moderna vaccine previously received. Treated with monoclonal antibody.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Underdose, Vaccine breakthrough infection
Clinical narrative: Narrative: Patient with breakthrough covid infection. He received only 1/2 doses of moderna vaccine. Treated with monoclonal antibody
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative: Patient with breakthrough covid infection. 2 doses of moderna vaccine received previously. Treated with monoclonal antibodies.
Age: 43.0
Sex: F
Vaccine: PPV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Narrative:
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/15, Pfizer, dose #1 02/05, Pfizer, dose #2 09/01 COVID swab, result: detected 09/01 pt cc: exposure: unknown 09/01 SARS-COV-2 LINEAGE result: AY .3 09/01 SARS- COV-2 CLADE result: 21 J (DELTA)
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Myalgia, Productive cough
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/16, Pfizer,  dose #1 02/06, Pfizer, dose #2 10/14, Pfizer, dose #3 09/01 COVID swab, result:  detected 09/01 pt cc: loss of taste or smell, myalgias, productive cough exposure: unknown 09/01 SARS-COV-2 LINEAGE result: B.1.617.2 09/01 SARS-COV-2 CLADE result: 21 J (DELTA)
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/16, Pfizer,  dose #1 02/06, Pfizer, dose #2 10/14, Pfizer, dose #3 09/01 COVID swab, result:  detected 09/01 pt cc: loss of taste or smell, myalgias, productive cough exposure: unknown 09/01 SARS-COV-2 LINEAGE result: B.1.617.2 09/01 SARS-COV-2 CLADE result: 21 J (DELTA)
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen normal, COVID-19, Chest X-ray abnormal, Chronic obstructive pulmonary disease, Fibrin D dimer
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/12 Janssen, dose #1 08/29 COVID swab, result: detected 08/29 pt cc: exposure: unknown 08/29 CXR impression: Negative for pneumonia can be occult on radiographs. Correlate clinically and with testing. 08/30 CXR impression: COPD changes. No alveolar infiltrate. 09/01 CXR impression: NO significant change. No acute  abnormality. 09/02 FIBRINOGEN: 258 09/02 DDIMER: 0.80 09/02 ESR F 09/03 FIBRINOGEN: 261 09/03 DDIMER: 0/57 09/03 ESR 09/08 clinically resolved 10/05 COVID swab, result: not detected 10/12 The COVID-19 Ag result: not detected
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate normal, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/12 Janssen, dose #1 08/29 COVID swab, result: detected 08/29 pt cc: exposure: unknown 08/29 CXR impression: Negative for pneumonia can be occult on radiographs. Correlate clinically and with testing. 08/30 CXR impression: COPD changes. No alveolar infiltrate. 09/01 CXR impression: NO significant change. No acute  abnormality. 09/02 FIBRINOGEN: 258 09/02 DDIMER: 0.80 09/02 ESR F 09/03 FIBRINOGEN: 261 09/03 DDIMER: 0/57 09/03 ESR 09/08 clinically resolved 10/05 COVID swab, result: not detected 10/12 The COVID-19 Ag result: not detected
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Aspiration, Atelectasis, Blood creatine phosphokinase normal, Blood fibrinogen increased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/17/2020, Pfizer, dose #1 01/07/2021, Pfizer, dose #2 10/06/2021 Pfizer, dose #3 08/30 pt cc: cognitively impaired exposure: unknown 08/30 COVID swab, result: detected 09/02 FIBRINOGEN 384 09/02 DDIMER 1.83 09/02 ESR 51 09/03 FIBRINOGEN 384 09/03 ESR 45 09/03 DDIMER 1.56 09/08 CK 56.0 09/08 CRP 3.109 09/08 FERRITIN 46.0 09/08 LACTIC ACID result: 0.79 09/08 COVID swab, result: detected 09/09 CTA PE impression: 1. No evidence for pulmonary embolism. 2. Bibasilar atelectasis and/ or consolidation with plugging of the lower lobe bronchi. 3. Debris in the distal trachea, suggesting aspiration. 3. Tracheomalacia. 5. Background of moderate to severe emphysema. 09/08 CXR Impression: Left lower lobe consolidation or atelectasis 09/09 SARS-COV-2 Variant Sequencing result: pending 09/09 ESR result: 66 09/09 Fibrinogen result: 459 09/09 DDIMER result: 1.44 09/09 PROCALCITONIN <0.05 09/10 ESR result: 35 09/10 Fibrinogen result: 541 09/10 DDIMER result: 1.17 09/10 PROCALCITONIN <0.05 9/11 ESR result: 70 09/11 Fibrinogen result: 555 09/1 DDIMER result: 1.38 09/12 SARS-COV-2 Variant Sequencing result: pending 09/12 ESR result: 72 09/12 Fibrinogen result: 459 09/12 DDIMER result: 1.56
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid, Bronchial secretion retention, C-reactive protein, COVID-19, Chest X-ray abnormal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/17/2020, Pfizer, dose #1 01/07/2021, Pfizer, dose #2 10/06/2021 Pfizer, dose #3 08/30 pt cc: cognitively impaired exposure: unknown 08/30 COVID swab, result: detected 09/02 FIBRINOGEN 384 09/02 DDIMER 1.83 09/02 ESR 51 09/03 FIBRINOGEN 384 09/03 ESR 45 09/03 DDIMER 1.56 09/08 CK 56.0 09/08 CRP 3.109 09/08 FERRITIN 46.0 09/08 LACTIC ACID result: 0.79 09/08 COVID swab, result: detected 09/09 CTA PE impression: 1. No evidence for pulmonary embolism. 2. Bibasilar atelectasis and/ or consolidation with plugging of the lower lobe bronchi. 3. Debris in the distal trachea, suggesting aspiration. 3. Tracheomalacia. 5. Background of moderate to severe emphysema. 09/08 CXR Impression: Left lower lobe consolidation or atelectasis 09/09 SARS-COV-2 Variant Sequencing result: pending 09/09 ESR result: 66 09/09 Fibrinogen result: 459 09/09 DDIMER result: 1.44 09/09 PROCALCITONIN <0.05 09/10 ESR result: 35 09/10 Fibrinogen result: 541 09/10 DDIMER result: 1.17 09/10 PROCALCITONIN <0.05 9/11 ESR result: 70 09/11 Fibrinogen result: 555 09/1 DDIMER result: 1.38 09/12 SARS-COV-2 Variant Sequencing result: pending 09/12 ESR result: 72 09/12 Fibrinogen result: 459 09/12 DDIMER result: 1.56
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Cognitive disorder, Emphysema, Fibrin D dimer, Foreign body in respiratory tract, Lung consolidation
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/17/2020, Pfizer, dose #1 01/07/2021, Pfizer, dose #2 10/06/2021 Pfizer, dose #3 08/30 pt cc: cognitively impaired exposure: unknown 08/30 COVID swab, result: detected 09/02 FIBRINOGEN 384 09/02 DDIMER 1.83 09/02 ESR 51 09/03 FIBRINOGEN 384 09/03 ESR 45 09/03 DDIMER 1.56 09/08 CK 56.0 09/08 CRP 3.109 09/08 FERRITIN 46.0 09/08 LACTIC ACID result: 0.79 09/08 COVID swab, result: detected 09/09 CTA PE impression: 1. No evidence for pulmonary embolism. 2. Bibasilar atelectasis and/ or consolidation with plugging of the lower lobe bronchi. 3. Debris in the distal trachea, suggesting aspiration. 3. Tracheomalacia. 5. Background of moderate to severe emphysema. 09/08 CXR Impression: Left lower lobe consolidation or atelectasis 09/09 SARS-COV-2 Variant Sequencing result: pending 09/09 ESR result: 66 09/09 Fibrinogen result: 459 09/09 DDIMER result: 1.44 09/09 PROCALCITONIN <0.05 09/10 ESR result: 35 09/10 Fibrinogen result: 541 09/10 DDIMER result: 1.17 09/10 PROCALCITONIN <0.05 9/11 ESR result: 70 09/11 Fibrinogen result: 555 09/1 DDIMER result: 1.38 09/12 SARS-COV-2 Variant Sequencing result: pending 09/12 ESR result: 72 09/12 Fibrinogen result: 459 09/12 DDIMER result: 1.56
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Procalcitonin, Red blood cell sedimentation rate increased, SARS-CoV-2 test, SARS-CoV-2 test positive, Serum ferritin normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/17/2020, Pfizer, dose #1 01/07/2021, Pfizer, dose #2 10/06/2021 Pfizer, dose #3 08/30 pt cc: cognitively impaired exposure: unknown 08/30 COVID swab, result: detected 09/02 FIBRINOGEN 384 09/02 DDIMER 1.83 09/02 ESR 51 09/03 FIBRINOGEN 384 09/03 ESR 45 09/03 DDIMER 1.56 09/08 CK 56.0 09/08 CRP 3.109 09/08 FERRITIN 46.0 09/08 LACTIC ACID result: 0.79 09/08 COVID swab, result: detected 09/09 CTA PE impression: 1. No evidence for pulmonary embolism. 2. Bibasilar atelectasis and/ or consolidation with plugging of the lower lobe bronchi. 3. Debris in the distal trachea, suggesting aspiration. 3. Tracheomalacia. 5. Background of moderate to severe emphysema. 09/08 CXR Impression: Left lower lobe consolidation or atelectasis 09/09 SARS-COV-2 Variant Sequencing result: pending 09/09 ESR result: 66 09/09 Fibrinogen result: 459 09/09 DDIMER result: 1.44 09/09 PROCALCITONIN <0.05 09/10 ESR result: 35 09/10 Fibrinogen result: 541 09/10 DDIMER result: 1.17 09/10 PROCALCITONIN <0.05 9/11 ESR result: 70 09/11 Fibrinogen result: 555 09/1 DDIMER result: 1.38 09/12 SARS-COV-2 Variant Sequencing result: pending 09/12 ESR result: 72 09/12 Fibrinogen result: 459 09/12 DDIMER result: 1.56
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, SARS-CoV-2 test
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/01, Pfizer, dose #1 04/05, Pfizer, dose #2 08/30 pt cc: cough, headache, fatigue, exposure:  unknown 08/30 COVID swab, result: detected 08/30 SARS-COV-2 Variant Sequencing result: pending
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/01, Pfizer, dose #1 04/05, Pfizer, dose #2 08/30 pt cc: cough, headache, fatigue, exposure:  unknown 08/30 COVID swab, result: detected 08/30 SARS-COV-2 Variant Sequencing result: pending
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/18, Pfizer, dose #2 10/12, Pfizer, dose #3 08/29 pt cc: chills, cough, fatigue, fever, headache, loss of taste or smell, myalgias, exposure: unknown 08/30 SARS-COV-2 Variant Sequencing result: pending 08/30 COVID swab, result: detected
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/18, Pfizer, dose #2 10/12, Pfizer, dose #3 08/29 pt cc: chills, cough, fatigue, fever, headache, loss of taste or smell, myalgias, exposure: unknown 08/30 SARS-COV-2 Variant Sequencing result: pending 08/30 COVID swab, result: detected
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/18, Pfizer, dose #2 10/12, Pfizer, dose #3 08/29 pt cc: chills, cough, fatigue, fever, headache, loss of taste or smell, myalgias, exposure: unknown 08/30 SARS-COV-2 Variant Sequencing result: pending 08/30 COVID swab, result: detected
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Diarrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/08, Pfizer, dose #1 04/01, Pfizer, dose #2 10/14, Pfizer, dose #3 08/21 pt cc: cough, fatigue, loss of taste or smell, fever diarrhea, exposure; unknown 08/30 COVID swab, result: detected 08/30 SARS-COV-2 Variant Sequencing result: pending 09/07 clinically resolved
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/08, Pfizer, dose #1 04/01, Pfizer, dose #2 10/14, Pfizer, dose #3 08/21 pt cc: cough, fatigue, loss of taste or smell, fever diarrhea, exposure; unknown 08/30 COVID swab, result: detected 08/30 SARS-COV-2 Variant Sequencing result: pending 09/07 clinically resolved
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Pyrexia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/16, Pfizer,  dose #1 02/06, Pfizer, dose #2 08/30, Pfizer, dose #3 08/30 pt cc: cough, fatigue, fever, headache, rhinorrhea exposure: unknown 0/30 COVID swab, result:  detected 09/27 COVID swab, result: detected
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/16, Pfizer,  dose #1 02/06, Pfizer, dose #2 08/30, Pfizer, dose #3 08/30 pt cc: cough, fatigue, fever, headache, rhinorrhea exposure: unknown 0/30 COVID swab, result:  detected 09/27 COVID swab, result: detected
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Headache, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/19, Pfizer, dose #2 08/03 pt cc: headache, rhinorrhea, sore throat, myalgias, dyspnea, cough exposure: unknown 08/30 SARS-COV-2 Variant Sequencing result: pending 08/30 COVID swab, result: detected 08/30 BinaxNOW COVID-19 Ag result: not detected
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/19, Pfizer, dose #2 08/03 pt cc: headache, rhinorrhea, sore throat, myalgias, dyspnea, cough exposure: unknown 08/30 SARS-COV-2 Variant Sequencing result: pending 08/30 COVID swab, result: detected 08/30 BinaxNOW COVID-19 Ag result: not detected
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/20, Pfizer, dose #1 02/09, Pfizer, dose #2 08/30 COVID SWAB, Result: detected 08/30 pt cc: exposure: unknown 08/30 SARS-COV-2 Variant Sequencing result: pending
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Pyrexia, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/28/2020, Pfizer, dose #1 01/19/2021, Pfizer, dose #2 08/28 pt cc: cough, fever exposure: unknown 08/30 COVID swab, result: detected 08/30 SARS-COV-2 Variant Sequencing result: pending 09/08 COVID swab, result: detected
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Chills, Cough, Diarrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/19, Moderna, dose #1 02/16, Moderna, dose #2 09/07 COVID swab, result: detected 08/24 pt cc: chills, cough, diarrhea, fatigue, fever, rhinorrhea, dyspnea, exposure: unknown 08/27 COVID swab, result: detected 08/27 SARS-COV-2 Variant Sequencing result: pending 08/28 pt admit to ED cc: cough & SOB, dx: LOS: 1 day 08/28 CXR impression: Similar radiographic appearance of the chest, as detailed above. 09/09 clinically rlesolved
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Pyrexia, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/19, Moderna, dose #1 02/16, Moderna, dose #2 09/07 COVID swab, result: detected 08/24 pt cc: chills, cough, diarrhea, fatigue, fever, rhinorrhea, dyspnea, exposure: unknown 08/27 COVID swab, result: detected 08/27 SARS-COV-2 Variant Sequencing result: pending 08/28 pt admit to ED cc: cough & SOB, dx: LOS: 1 day 08/28 CXR impression: Similar radiographic appearance of the chest, as detailed above. 09/09 clinically rlesolved
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/19, Moderna, dose #1 02/16, Moderna, dose #2 09/07 COVID swab, result: detected 08/24 pt cc: chills, cough, diarrhea, fatigue, fever, rhinorrhea, dyspnea, exposure: unknown 08/27 COVID swab, result: detected 08/27 SARS-COV-2 Variant Sequencing result: pending 08/28 pt admit to ED cc: cough & SOB, dx: LOS: 1 day 08/28 CXR impression: Similar radiographic appearance of the chest, as detailed above. 09/09 clinically rlesolved
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Diarrhoea
Clinical narrative: Narrative:  COVID infection COVID vaccine series 03/29, Moderna , dose #1 04/26, Moderna , dose #2 08/27 COVID swab, result: detected 08/24 pt cc: cough, diarrhea, fatigue, fever, headache, loss of taste or smell, myalgias,  rhinorrhea, congestion, dyspnea, sore throat, exposure: co-workers 08/27 SARS- COV-2 Variant Sequencing result: pending
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Exposure to SARS-CoV-2, Fatigue, Headache, Myalgia
Clinical narrative: Narrative:  COVID infection COVID vaccine series 03/29, Moderna , dose #1 04/26, Moderna , dose #2 08/27 COVID swab, result: detected 08/24 pt cc: cough, diarrhea, fatigue, fever, headache, loss of taste or smell, myalgias,  rhinorrhea, congestion, dyspnea, sore throat, exposure: co-workers 08/27 SARS- COV-2 Variant Sequencing result: pending
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Narrative:  COVID infection COVID vaccine series 03/29, Moderna , dose #1 04/26, Moderna , dose #2 08/27 COVID swab, result: detected 08/24 pt cc: cough, diarrhea, fatigue, fever, headache, loss of taste or smell, myalgias,  rhinorrhea, congestion, dyspnea, sore throat, exposure: co-workers 08/27 SARS- COV-2 Variant Sequencing result: pending
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection COVID vaccine series 03/29, Moderna , dose #1 04/26, Moderna , dose #2 08/27 COVID swab, result: detected 08/24 pt cc: cough, diarrhea, fatigue, fever, headache, loss of taste or smell, myalgias,  rhinorrhea, congestion, dyspnea, sore throat, exposure: co-workers 08/27 SARS- COV-2 Variant Sequencing result: pending
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/29, Moderna, dose #1 04/26, Moderna , dose #2 08/27 COVID swab, result:  detected 08/27 pt cc: exposure: unknown
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chest X-ray normal, Chest pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 08/26 pt cc: cough, fever, loss of taste or smell. dyspnea, exposure: unknown 08/27 SARS-COV-2 Variant Sequencing result: pending 09/07 COVID swab, result: detected 09/09 CXR impression: No acute cardiopulmonary process is detected 09/09 pt admit cc: cp dx: hauler syndrome LOS: 1 day 09/23 COVID swab, result: not detected
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Post-acute COVID-19 syndrome, Pyrexia, SARS-CoV-2 test
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 08/26 pt cc: cough, fever, loss of taste or smell. dyspnea, exposure: unknown 08/27 SARS-COV-2 Variant Sequencing result: pending 09/07 COVID swab, result: detected 09/09 CXR impression: No acute cardiopulmonary process is detected 09/09 pt admit cc: cp dx: hauler syndrome LOS: 1 day 09/23 COVID swab, result: not detected
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 08/26 pt cc: cough, fever, loss of taste or smell. dyspnea, exposure: unknown 08/27 SARS-COV-2 Variant Sequencing result: pending 09/07 COVID swab, result: detected 09/09 CXR impression: No acute cardiopulmonary process is detected 09/09 pt admit cc: cp dx: hauler syndrome LOS: 1 day 09/23 COVID swab, result: not detected
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/14, Moderna , dose #1 05/04, Moderna , dose #2 08/12 COVID swab, result: not detected 08/27 COVID swab, result: detected 08/27 pt cc: No symptoms exposure: unknown 08/27 SARS-COV-2 Variant Sequencing result: pending
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/02 , Pfizer, dose #1 02/23, Pfizer, dose #2 08/27 COVID swab, result: detected 08/27 pt cc: cough exposure: unknown
Age: 52.0
Sex: M
Vaccine: FLU4, PPV
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Dyspnoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/10, Pfizer, Moderna #1 03/10 Pfizer, Moderna #2 0825 pt cc: cough, fever, headache, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure: unknown clinically resolved 08/27 COVID swab, result: detected 08/27 SARS-COV-2 Variant Sequencing result: pending
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/10, Pfizer, Moderna #1 03/10 Pfizer, Moderna #2 0825 pt cc: cough, fever, headache, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure: unknown clinically resolved 08/27 COVID swab, result: detected 08/27 SARS-COV-2 Variant Sequencing result: pending
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/10, Pfizer, Moderna #1 03/10 Pfizer, Moderna #2 0825 pt cc: cough, fever, headache, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure: unknown clinically resolved 08/27 COVID swab, result: detected 08/27 SARS-COV-2 Variant Sequencing result: pending
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/23, Pfizer, dose #1 06/01 COVID swab, result: not detected 02/12, Pfizer, dose #2 08/27 COVID swab, result: detected 08/27 SARS-COV-2 Variant Sequencing result:  pending 08/29 pt cc: NO SYMPTOMS exposure: unknown 09/28 COVID swab, result: not detected
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Aphasia, COVID-19, Cognitive disorder, Death, SARS-CoV-2 test
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/28, Pfizer, dose #1 Agency Facility 02/06, Pfizer, dose #2 (PHARMACY) 08/12 08/23 08/26 COVID swab , result: not detected 08/16 08/23 08/26 COVID swab , result: not detected 08/19 08/23 08/26 COVID swab , result: not detected 08/23 08/26 COVID swab , result: not detected 08/26 COVID swab , result: detected 08/26 SARS-COV-2 Variant Sequencing results: pending 08/27 pt cognitively impaired admitted to nursing home COVID unit for quarantine and supportive care. 08/27 pt cc: unable to verbalize exposure: unknown 10/03 pt deceased
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/28, Pfizer, dose #1 Agency Facility 02/06, Pfizer, dose #2 (PHARMACY) 08/12 08/23 08/26 COVID swab , result: not detected 08/16 08/23 08/26 COVID swab , result: not detected 08/19 08/23 08/26 COVID swab , result: not detected 08/23 08/26 COVID swab , result: not detected 08/26 COVID swab , result: detected 08/26 SARS-COV-2 Variant Sequencing results: pending 08/27 pt cognitively impaired admitted to nursing home COVID unit for quarantine and supportive care. 08/27 pt cc: unable to verbalize exposure: unknown 10/03 pt deceased
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Disorientation, Feeling abnormal, Gait disturbance
Clinical narrative: Narrative:  71 YO M w/ PMHx of T2DM reports feeling very weak and  disorientated ~12 hours after second COVID-19 vaccine. Patient recalls it was as if his "brain and muscles weren't communicating." Patient had trouble walking and had to crawl up the stairs at sometimes. Patient denies myalgias/fever/cough/pain. Sx resolved without treatment within the following 3 next days.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/24 , Pfizer, dose #1 03/17, Pfizer, dose #2 09/29, Pfizer, dose #3 08/26 COVID swab, result:  detected 08/26 pt cc: No symptoms exposure: unknown 08/27 CXR- impression: clinically resolved 09/10 CXR impression: NO evidence of acute cardiopulmonary process.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chest X-ray abnormal, Dyspnoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/23, Moderna , dose #1 02/10, Moderna , dose #2 02/11 08/26 COVID swab, result: not detected 08/10 pt cc: DYSPNEA, loss of taste or smell exposure: unknown 08/18 CXR impression: Peripheral patchy bilateral infiltrates commonly seen with Covid 19 pneumonia. No pneumothorax. 08/21 clinically resolved 08/26 COVID swab, result: detected 09/08 SARS-COV-2 Variant Sequencing result: pending
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Lung infiltration, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/23, Moderna , dose #1 02/10, Moderna , dose #2 02/11 08/26 COVID swab, result: not detected 08/10 pt cc: DYSPNEA, loss of taste or smell exposure: unknown 08/18 CXR impression: Peripheral patchy bilateral infiltrates commonly seen with Covid 19 pneumonia. No pneumothorax. 08/21 clinically resolved 08/26 COVID swab, result: detected 09/08 SARS-COV-2 Variant Sequencing result: pending
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Narrative:  Patient was sitting in observation area and approximately 5 minutes after receiving the Pfizer booster and Flu shot she looked up and stated her vision was mildly blurry for a few moments. Patient was monitored the remainder of her 15 minutes, no other signs/symptoms were stated/observed. After her 15 minute  observation period the patient stated the blurriness had completely resolved, and  stated that she had no other complaints and she requested to leave.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Atelectasis, COVID-19, Chest X-ray abnormal, Cognitive disorder, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 12/16/2020 Pfizer, dose #1 01/06/2021, Pfizer, dose #2 10/01/2021 Pfizer, dose #3 08/18 CXR impression: Suspected residual bronchovascular crowding and atelectasis rather than residual/recurrent infiltrate right lung base, otherwise no radiographic evidence of acute cardiopulmonary disease. 08/23 COVID swab, result: not detected 08/27 COVID swab, result: detected 08/27 pt cc: exposure:  unknown 08/30 CXR: FINDINGS AND IMPRESSION: Support devices: None identified Mediastinum: Normal cardiac size. No central pulmonary vascular enlargement. Lungs and pleura: no dense consolidation or pleural effusion is identified. Bones: Unchanged 09/02 pt cognitively impaired admitted to  COVID unit 09/07 clinically resolved 09/16 COVID swab, result: not detected
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 08/27 COVID swab, result: detected 08/27 pt cc: NO SYMPTOMS exposure: unknown
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Fatigue, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/29 Janssen, dose #1 08/27 COVID swab, result: detected 08/27 Pt cc: cough, fatigue, rhinorrhea, sore throat, exposure: family 08/27 SARS-COV-2 Variant Sequencing result: pending 08/27 pt admit to ED cc: cough dx: PUI LOS: 1 day
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/29 Janssen, dose #1 08/27 COVID swab, result: detected 08/27 Pt cc: cough, fatigue, rhinorrhea, sore throat, exposure: family 08/27 SARS-COV-2 Variant Sequencing result: pending 08/27 pt admit to ED cc: cough dx: PUI LOS: 1 day
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Exposure to SARS-CoV-2
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 12/30/2021, Pfizer, dose #1 01/19/2021 Pfizer, dose #2 08/15 pt cc: cough, fatigue, loss of taste or smell, rhinorrhea, exposure: friend 08/27 COVID swab, result: detected
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 12/30/2021, Pfizer, dose #1 01/19/2021 Pfizer, dose #2 08/15 pt cc: cough, fatigue, loss of taste or smell, rhinorrhea, exposure: friend 08/27 COVID swab, result: detected
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Headache, Myalgia, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, MODERNA, dose#1 03/26, MODERNA, dose #2 08/27 COVID swab, result: detected 08/27 SARS-COV-2 Variant Sequencing RESULT: pending 08/25 pt cc: fatigue, headache, myalgias, rhinorrhea exposure: unknown
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, MODERNA, dose#1 03/26, MODERNA, dose #2 08/27 COVID swab, result: detected 08/27 SARS-COV-2 Variant Sequencing RESULT: pending 08/25 pt cc: fatigue, headache, myalgias, rhinorrhea exposure: unknown
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/04,  MODERNA, dose #1 02/02, MODERNA, dose #2 08/27 COVID swab, result: detected 08/27 pt cc: exposure: unknown
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, COVID-19, Chest X-ray abnormal, Cough, Fatigue
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/15, Pfizer,  dose #1 02/05, Pfizer, dose #2 06/18 DDIMER result: 0.77 06/18 CXR impression: Pronounced peribronchial vessels centrally, RIGHT more than LEFT, could reflect true interstitial pulmonary edema or ongoing bronchitis. Alternatively consider artifact due to portable technique. Needs correlation for signs and  symptoms of systemic volume overload versus lower respiratory tract infection. No focal pneumonia or pleural effusion. 08/17 pt cc: cough, rhinorrhea, fatigue exposure: unknown 08/26 COVID swab, result: detected 08/26 SARS-COV-2 Variant Sequencing RESULT: pending 08/30 clinically resolved
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Pulmonary oedema, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/15, Pfizer,  dose #1 02/05, Pfizer, dose #2 06/18 DDIMER result: 0.77 06/18 CXR impression: Pronounced peribronchial vessels centrally, RIGHT more than LEFT, could reflect true interstitial pulmonary edema or ongoing bronchitis. Alternatively consider artifact due to portable technique. Needs correlation for signs and  symptoms of systemic volume overload versus lower respiratory tract infection. No focal pneumonia or pleural effusion. 08/17 pt cc: cough, rhinorrhea, fatigue exposure: unknown 08/26 COVID swab, result: detected 08/26 SARS-COV-2 Variant Sequencing RESULT: pending 08/30 clinically resolved
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vasodilatation
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/15, Pfizer,  dose #1 02/05, Pfizer, dose #2 06/18 DDIMER result: 0.77 06/18 CXR impression: Pronounced peribronchial vessels centrally, RIGHT more than LEFT, could reflect true interstitial pulmonary edema or ongoing bronchitis. Alternatively consider artifact due to portable technique. Needs correlation for signs and  symptoms of systemic volume overload versus lower respiratory tract infection. No focal pneumonia or pleural effusion. 08/17 pt cc: cough, rhinorrhea, fatigue exposure: unknown 08/26 COVID swab, result: detected 08/26 SARS-COV-2 Variant Sequencing RESULT: pending 08/30 clinically resolved
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Myalgia, Nausea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/09, Pfizer, dose #1 03/29, Pfizer, dose #2 08/24 pt cc: cough, fatigue, fever, myalgias, nausea, sore throat exposure: unknown 08/26 COVID swab, result: detected 08/26 SARS-COV-2 Variant Sequencing result: pending
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/09, Pfizer, dose #1 03/29, Pfizer, dose #2 08/24 pt cc: cough, fatigue, fever, myalgias, nausea, sore throat exposure: unknown 08/26 COVID swab, result: detected 08/26 SARS-COV-2 Variant Sequencing result: pending
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19, Pfizer, dose #1 04/08, Pfizer, dose #2 08/26 SARS-COV-2 Variant Sequencing result;  pending 08/26 COVID swab, result: detected 08/24 pt cc: chills,cough,diarrhea,fatigue, fever, headache, loss of taste or smell rhinorrhea  exposure: son clinically resolved
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Exposure to SARS-CoV-2, Fatigue, Headache, Pyrexia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19, Pfizer, dose #1 04/08, Pfizer, dose #2 08/26 SARS-COV-2 Variant Sequencing result;  pending 08/26 COVID swab, result: detected 08/24 pt cc: chills,cough,diarrhea,fatigue, fever, headache, loss of taste or smell rhinorrhea  exposure: son clinically resolved
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19, Pfizer, dose #1 04/08, Pfizer, dose #2 08/26 SARS-COV-2 Variant Sequencing result;  pending 08/26 COVID swab, result: detected 08/24 pt cc: chills,cough,diarrhea,fatigue, fever, headache, loss of taste or smell rhinorrhea  exposure: son clinically resolved
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Dyspnoea, Oropharyngeal pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/19, Pfizer, dose #2 08/20 pt cc: cough, diarrhea, rhinorrhea, dyspnea, sore throat exposure: unknown 08/26 COVID swab, result: detected
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/19, Pfizer, dose #2 08/20 pt cc: cough, diarrhea, rhinorrhea, dyspnea, sore throat exposure: unknown 08/26 COVID swab, result: detected
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Atelectasis, Brain natriuretic peptide normal, COVID-19, Chest X-ray abnormal, Fibrin D dimer normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/18, Pfizer, dose #1 03.11, Pfizer, dose #2 09/24, Pfizer, dose #3 08/26 COVID swab, result: detected 08/26 pt cc: no symptoms exposure: unknown 08/26 DDIMER result: 0.27 08/26 BNP result: 92.8 08/26 SARS-COV-2 Variant Sequencing result:  pending 08/26 CXR impression: no acute cardio-pulmonary finding 09/28 CXR impression: lung hyperinflation may be secondary to vigorous inspiratory effort versus air trapping. 2. Progressive left basilar opacities may represent residual atelectasis/scarring from reported pneumonia. Similar right basilar atelectasis/scar. Correlation with clinical symptomatology is needed. Consider follow-up imaging to confirm resolution or stability.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Lung hyperinflation, Lung opacity, Pulmonary fibrosis, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/18, Pfizer, dose #1 03.11, Pfizer, dose #2 09/24, Pfizer, dose #3 08/26 COVID swab, result: detected 08/26 pt cc: no symptoms exposure: unknown 08/26 DDIMER result: 0.27 08/26 BNP result: 92.8 08/26 SARS-COV-2 Variant Sequencing result:  pending 08/26 CXR impression: no acute cardio-pulmonary finding 09/28 CXR impression: lung hyperinflation may be secondary to vigorous inspiratory effort versus air trapping. 2. Progressive left basilar opacities may represent residual atelectasis/scarring from reported pneumonia. Similar right basilar atelectasis/scar. Correlation with clinical symptomatology is needed. Consider follow-up imaging to confirm resolution or stability.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Atelectasis, COVID-19, Chest X-ray abnormal, Chest pain, Chills
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 03/29 pt admit to medicine cc: chest pain Dx: atypical chest pain LOS: 3 days 03/29 CXR impression: Bilateral lung base atelectasis. No focal consolidation that is typical of pneumonia. 07/04 COVID swab, result: not detected 08/26 pt cc: cough, chills, diarrhea, fatigue, exposure: unknown 08/26 COVID swab, result: detected 08/26 SARS-COV-2 Variant Sequencing result: pending
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Fatigue, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 03/29 pt admit to medicine cc: chest pain Dx: atypical chest pain LOS: 3 days 03/29 CXR impression: Bilateral lung base atelectasis. No focal consolidation that is typical of pneumonia. 07/04 COVID swab, result: not detected 08/26 pt cc: cough, chills, diarrhea, fatigue, exposure: unknown 08/26 COVID swab, result: detected 08/26 SARS-COV-2 Variant Sequencing result: pending